Komipharm International Co. Ltd (041960) — Cash Flow Reinvestment Rate
Komipharm International Co. Ltd (041960) has a Cash Flow Reinvestment Rate of 5.10x as of December 2025, reinvesting ₩4.83 Billion (capex ₩1.85 Billion plus investments ₩2.98 Billion) from operating cash flow of ₩946.94 Million. Explore Komipharm International Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Komipharm International Co. Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Komipharm International Co. Ltd across 6 annual periods. Also explore Komipharm International Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Komipharm International Co. Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Komipharm International Co. Ltd. For live market cap and broader valuation context, see 041960 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.67x | ₩5.96 Billion | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.1% |
| 2020 | 76.26x | ₩1.92 Billion | ₩25.20 Million | ₩1.66 Billion | ▲ +1149.9% |
| 2019 | 6.10x | ₩5.80 Billion | ₩950.79 Million | ₩5.74 Billion | ▼ -57.5% |
| 2017 | 14.35x | ₩3.38 Billion | ₩235.64 Million | ₩2.68 Billion | ▲ +5.5% |
| 2016 | 13.60x | ₩16.43 Billion | ₩1.21 Billion | ₩12.24 Billion | ▲ +114.6% |
| 2013 | 6.34x | ₩24.93 Billion | ₩3.93 Billion | ₩24.93 Billion | — |